NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacyTakahiro Miyazaki, Jonathan Zalevsky, Ping Zhang et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 55
NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cellsTanya O. Robinson, Kimberly S. Schluns, Shweta Hegde et al.|Journal of Clinical Investigation|2021Cited by 25
Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Nancy Gordon, Andrew Wahba et al.|International Journal of Cancer|2020Cited by 20
NKTR-255, a Polymer-Conjugated IL-15 Enhances Antibody-Dependent Cellular Cytotoxicity Mediated By NK Cells in a B Cell Lymphoma ModelTakahiro Miyazaki, Jonathan Zalevsky, Saul Kivimäe et al.|Blood|2019Cited by 5
Pharmacokinetic and Pharmacodynamic Study of NKTR-255, a Polymer-Conjugated Human IL-15, in Cynomolgus MonkeyTakahiro Miyazaki, Jonathan Zalevsky, Peiwen Kuo et al.|Blood|2018Cited by 4